Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...
In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.90, marking a -4.88% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.51% for ...
Additionally, Recursion Pharmaceuticals plans to present updated clinical data from the TUPELO trial in a webinar scheduled for December 8, 2025. The webinar will provide more insights into the safety ...
It comes as no surprise that artificial intelligence is at the heart of the opportunity. This application of AI, in fact, is arguably one of the best uses of this young technology. The chief stumbling ...
In winter 2026, the Olympics head to Milan, Italy, where athletes from over 200 delegations will compete for medals in respective competitions. From the perennial Olympics powerhouses like the United ...
We've now combed through hundreds of thousands of files, photos and videos. They stretch back decades but their effect has been immediate. All week we have said that being mentioned in the files is ...
Jonathan Kwan is an Assistant Professor of Philosophy at New York University Abu Dhabi and was previously the Markkula Center’s Inclusive Excellence Postdoctoral Fellow in Immigration Ethics. Views ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results